ESR1 and breast cancer: Inhibition of β-catenin by RNAi resulted in a significant decrease in estrogen receptor alpha (ERα) mRNA and protein levels in MCF-7, T-47D, and BT-474 breast cancer cells, while also leading to a significant reduction in the growth of MCF-7 cells both in the presence and absence of estradiol [10].